MNLO - Menlo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Menlo Therapeutics's activity chart (see below) currently has 11 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 9.09% with an average time for these price targets to be met of 2.64 days.

Most recent stock forecast was given by TIM CHIANG from on 01-Jun-2020. First documented stock forecast 09-Apr-2018.

Best performing analysts who are covering MNLO - Menlo Therapeutics:

David Steinberg Oren Livnat Balaji Prasad Donald Ellis Louise Chen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Jun-2020

$6

$-154.56 (-96.26%)

6 years 3 months 26 days ago
(01-Jun-2020)

0/1 (0%)

$-164.64 (-96.48%)

Buy Since 13-May-2020

$3

$-157.56 (-98.13%)

6 years 4 months 14 days ago
(13-May-2020)

0/1 (0%)

$-119.4 (-97.55%)

Buy Since 18-Oct-2019

$2.5

$-158.06 (-98.44%)

$9

6 years 4 months 15 days ago
(12-May-2020)

0/3 (0%)

$-127.82 (-98.08%)

Hold

$7

$4.77 (213.90%)

7 years 11 months 18 days ago
(09-Oct-2018)

1/1 (100%)

$0.74 (11.82%)

29

Buy Since 06-Sep-2018

$25

$-135.56 (-84.43%)

8 years 21 days ago
(06-Sep-2018)

0/1 (0%)

$-524.36 (-95.45%)

Show more analysts

Please expand the browser size to see the chart

What is MNLO (Menlo Therapeutics) average time for price targets to be met?

On average it took 3 days for the stock forecasts to be reached, with an average price target met ratio of 9.09%.

Which analyst most recently updated their price target on MNLO (Menlo Therapeutics)?

Timothy Chiang

Which analyst has the most public recommendations on MNLO (Menlo Therapeutics)?

Timothy Chiang has 7 price targets and 12 ratings on MNLO

Which analyst is the currently most bullish on MNLO (Menlo Therapeutics)?

David Steinberg with the highest potential upside of $4.77

Which analyst is the currently most reserved on MNLO (Menlo Therapeutics)?

Oren Livnat with the lowest potential downside of -$158.06
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?